<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS206431</article-id><article-id pub-id-type="doi">10.1101/2025.06.10.656594</article-id><article-id pub-id-type="archive">PPR1034718</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Brain cholesterol metabolites cause significant neurodegeneration in human iPSC-derived neurons</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Yuqing</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mazumder</surname><given-names>Bismoy</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Konno</surname><given-names>Tasuku</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hui</surname><given-names>Ernestine</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brockhoff</surname><given-names>Marius</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Davi</surname><given-names>Valentina</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ward</surname><given-names>Edward</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stephens</surname><given-names>Amberley</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Wenyue</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fernandez-Villegas</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fusco</surname><given-names>Giuliana</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Asgari</surname><given-names>Mohsen Ali</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Avezov</surname><given-names>Edward</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>De Simone</surname><given-names>Alfonso</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yuqin</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Griffiths</surname><given-names>William J</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kaminski</surname><given-names>Clemens</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schierle</surname><given-names>Gabriele Kaminski</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Chemical Engineering and Biotechnology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap>, Philippa Fawcett Drive, <city>Cambridge</city>, <country country="GB">United Kingdom</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02wedp412</institution-id><institution>UK Dementia Research Institute</institution></institution-wrap> at <institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap>, Department of Clinical Neurosciences, <city>Cambridge</city>, <country country="GB">United Kingdom</country></aff><aff id="A3"><label>3</label>Department of Pharmacy, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05290cv24</institution-id><institution>University of Naples Federico II</institution></institution-wrap>, <postal-code>80131</postal-code><city>Naples</city>, <country country="IT">Italy</country></aff><aff id="A4"><label>4</label>Institute of Life Science 1, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/053fq8t95</institution-id><institution>Swansea University</institution></institution-wrap> Medical School, <addr-line>Singleton Park</addr-line>, <city>Swansea</city>, <country country="GB">United Kingdom</country></aff><author-notes><fn id="FN1" fn-type="present-address"><label>*</label><p id="P1">Current address: Institute of Advanced Clinical Medicine, Peking University, China</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>14</day><month>06</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>11</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P2">Disrupted cholesterol metabolism is increasingly recognised as a contributing factor in neurodegeneration; however, the specific effects of key brain-derived cholesterol metabolites, 24S-hydroxycholesterol (24S-HC) and 27-hydroxycholesterol (27-HC), remain poorly understood. Using human iPSC-derived i<sup>3</sup> cortical neurons, we demonstrate that both 24S-HC and 27-HC significantly impair neuronal calcium signalling by elevating resting calcium levels, reducing spike amplitude, and disrupting network synchrony. These functional deficits are accompanied by widespread organelle dysfunction. Both oxysterols induce mitochondrial fragmentation, decrease spare respiratory capacity, and impair lysosomal degradation. Notably, 27-HC uniquely triggers lysosomal swelling and membrane permeabilisation. Additional signs of cellular stress, including axonal swellings and elevated endoplasmic reticulum calcium levels, were also observed. Furthermore, both 24S-HC and 27-HC were found to directly interact with alpha-synuclein (aSyn), promoting its accumulation in cellular models. In contrast, cholesterol itself had minimal impact, highlighting the distinct toxicity of its hydroxylated metabolites. Together, these findings reveal a mechanistic link between oxysterol accumulation and neuronal dysfunction, supporting the hypothesis that elevated levels of 24S-HC and 27-HC, commonly observed in Parkinson’s and Alzheimer’s disease, may actively drive neurodegenerative processes. Targeting oxysterol metabolism may therefore represent a promising therapeutic avenue for intervention in neurodegenerative disorders.</p></abstract><kwd-group><kwd>cholesterol</kwd><kwd>24S-hydroxycholesterol</kwd><kwd>27-hydroxycholesterol</kwd><kwd>calcium signalling</kwd><kwd>mitochondria</kwd><kwd>lysosomes</kwd><kwd>endoplasmic reticulum</kwd><kwd>neurodegeneration</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">The brain contains the highest concentration of sterols in the body<sup><xref ref-type="bibr" rid="R1">1</xref></sup>, primarily in the form of cholesterol, along with its precursors 7-dehydrocholesterol and desmosterol<sup><xref ref-type="bibr" rid="R2">2</xref></sup>, and its metabolites 24S-hydroxycholesterol (24S-HC), and to a lesser extent, 27-hydroxycholesterol (27-HC, formally (25R)26-hydroxycholesterol)<sup><xref ref-type="bibr" rid="R3">3</xref></sup>. Cholesterol is mainly synthesised in astrocytes and, due to the blood–brain barrier (BBB), cannot cross into or out of the brain<sup><xref ref-type="bibr" rid="R4">4</xref></sup>. To maintain cholesterol homeostasis, excess cholesterol is transported to neurons and converted by the enzyme CYP46A1 into 24S-HC<sup><xref ref-type="bibr" rid="R5">5</xref></sup>, which, owing to its additional hydroxyl group, can exit the brain via circulation<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. In contrast, 27-HC is predominantly produced in the liver by CYP27A1 and can enter the brain by crossing the BBB<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Under normal conditions, both 24S-HC and 27-HC help regulate cholesterol transport and maintain brain cholesterol homeostasis<sup><xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>.</p><p id="P4">Disruptions in cholesterol metabolism, particularly involving 24S-HC and 27-HC, have been implicated in neurodegenerative diseases<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref></sup>. Several factors may contribute to their elevated levels in the brain. As the brain ages, cholesterol accumulates, particularly due to processes like myelin breakdown, which in turn can elevate the production of 24S-HC<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. At the same time, systemic metabolic changes, such as those induced by high-cholesterol diets, lead to increased hepatic synthesis of 27-HC, raising its levels in circulation and promoting its entry into the brain<sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. This influx is further exacerbated by age-associated breakdown of the BBB<sup><xref ref-type="bibr" rid="R14">14</xref></sup>, which becomes more permeable over time, allowing greater passage of peripheral 27-HC into the brain parenchyma<sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>. Clinically, such dysregulation is reflected in elevated concentrations of 24S-HC in the cerebrospinal fluid (CSF) of individuals with Parkinson’s disease (PD)<sup><xref ref-type="bibr" rid="R15">15</xref></sup> and Alzheimer’s disease (AD)<sup><xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R18">18</xref></sup> and, alongside increased levels of 27-HC and its metabolites, in the CSF of PD patients<sup><xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>. These metabolites are not merely biomarkers: both have been implicated in neurotoxic processes, including alpha-synuclein (aSyn) aggregation in PD<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. Moreover, 27-HC has been shown to contribute to amyloid-beta (Aβ) accumulation and tau phosphorylation, key hallmarks of AD pathology<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>.</p><p id="P5">Neuronal calcium signalling plays a central role in regulating synaptic plasticity and neurotransmission<sup><xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>. Intracellular calcium levels are tightly controlled through membrane channels and exchanges with internal stores, such as the endoplasmic reticulum (ER), mitochondria but also lysosomes<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>, which are frequently impaired in neurodegeneration<sup><xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R31">31</xref></sup>. Thus, understanding how cholesterol metabolites affect calcium dynamics and organelle health could uncover new mechanisms underlying neurodegenerative disease.</p><p id="P6">In this study, we utilised i<sup>3</sup> cortical neurons derived from human induced pluripotent stem cells (iPSCs)<sup><xref ref-type="bibr" rid="R32">32</xref></sup> to investigate the cellular and organelle-level effects of cholesterol, 24S-HC, and 27-HC. Using live-cell calcium imaging, structured illumination microscopy (SIM), and complementary biochemical assays, we show that 24S-HC and 27-HC impair calcium signalling and disrupt mitochondrial, lysosomal, and ER function. Given that cholesterol is known to directly interact with aSyn<sup><xref ref-type="bibr" rid="R33">33</xref></sup>, we further investigated whether these oxysterols influence aSyn dynamics. Our results demonstrate that both 24S-HC and 27-HC bind to aSyn with significantly higher affinity than cholesterol and promote its accumulation in cellular models. These findings establish a mechanistic link between cholesterol metabolites and neurodegenerative processes, particularly in the context of PD. They also highlight the potential of targeting elevated 24S-HC and 27-HC levels as a novel therapeutic strategy for mitigating aSyn pathology and disease progression.</p></sec><sec id="S2" sec-type="methods"><title>Methods</title><sec id="S3"><title>i<sup>3</sup> neuronal cell culture</title><p id="P7">i<sup>3</sup> neurons were differentiated from human iPSCs as previously described<sup><xref ref-type="bibr" rid="R32">32</xref></sup>. Briefly, human iPSCs were cultured in StemFlex medium in 6-well cell culture plates with Vitronectin coating and split with Accutase while reaching 80 % confluence. After two or three passages, human iPSCs were differentiated in DMEM/F12, HEPES supplemented with 1X N-2 supplement, 1X non-essential amino acids, 1X antibiotic-antimycotic, 50 μM 2-mercaptoethanol and 1 μg/mL doxycycline hyclate in 6-well cell culture plates with Geltrex coating. After daily media change for 3 days, cells were split and transferred to Neurobasal medium supplemented with 1X B-27 supplement, 2 mM GlutaMAX supplement, 1X antibiotic-antimycotic, 50 μM 2-mercaptoethanol, 1 μg/mL doxycycline hyclate, 10 ng/mL NT-3, and 10 ng/mL BDNF. Full media was changed for four days followed by half media change every other day until day 21 in vitro (DIV). From 21 DIV onwards, full media was changed every other day. 10 μM ROCK inhibitor was added every time when plating cells. For different imaging purposes, 120,000 cells/well were plated in μ-slide 8 well high glass bottom plates (Nunc Lab-Tek II Chambered Coverglass), or 40,000-45,000 cells/well were plated in 96-well plates, all coated with 0.01% poly-l-lysine (PLL).</p></sec><sec id="S4"><title>COS-7 cell culture</title><p id="P8">COS-7 cells purchased from the American Type Culture Collection (ATCC) were cultured at 37°C with a 5% CO<sub>2</sub> atmosphere. The cell culture media is composed of 90% Dulbecco’s Modified Eagle’s Medium-high glucose (DMEM), 10% fetal bovine serum (FBS), 2 mM GlutaMAX supplement, and 1X antibiotic-antimycotic. COS-7 cells were passaged when they reached 80-90% confluence.</p></sec><sec id="S5"><title>HEK cell culture and lentivirus production</title><p id="P9">Human embryonic kidney 293 (HEK293) cells purchased from ATCC were cultured at 37°C with a 5% CO<sub>2</sub> atmosphere with the same media as COS-7 cells but without antibiotics. When the confluence reached 80-90%, HEK293 cells were transfected with mEmerald-KDEL plasmid, or ER-GCaMP6-150 using 3rd generation lentiviruses: pMDLg_pRRE, pRSV-Rev, pMD2.G. The transfection was performed using Lipofectamine 2000 transfection reagent or polyethyleneimine (PEI) with a plasmid ratio of 2:1:1:4 (pMDLg_pRRE : pRSV-Rev : pMD2.G: transfer plasmid). After 72 h of incubation, cell media was harvested with 5 minutes centrifugation at 500 x g and filtered with a 0.45 μm filter. To concentrate, lentiviruses were incubated with 4 x lentivirus concentrator solution (40% w/v PEG-8000 and 1.2 M NaCl in PBS, pH 7), shaking at 60 rpm overnight at 4 °C, followed by spinning down at 1600 x g for 1 h. After removing the supernatant, the pellet was resuspended in PBS and aliquoted to working volume.</p></sec><sec id="S6"><title>Cholesterol, 24S-HC and 27-HC preparation</title><p id="P10">Cholesterol (ovine), 24S-HC and 27-HC were dissolved in dimethyl sulfoxide (DMSO) or ethanol to a stock concentration of 5 mM and aliquoted to amber glass vials to store at -20 °C.</p></sec><sec id="S7"><title>Cholesterol, 24S-HC, 27-HC and drug treatment</title><p id="P11">Unless specified, i<sup>3</sup> neurons (26-27 DIV) were treated for 3 days with 10 μM cholesterol, 10 μM 24S-HC or 10 μM 27-HC with replenishment when changing the media. For lysosomal morphology treatment, 10 μM U18666A was added for 3 days as a positive control.</p></sec><sec id="S8"><title>Organelle staining</title><sec id="S9"><title>Mitochondria</title><p id="P12">On the day of imaging, mitochondria were stained with 50 nM MitoTracker Deep Red or MitoTracker Orange CMTMRos for 30 minutes, followed by washing the cells once with culture media.</p></sec><sec id="S10"><title>Lysosome</title><p id="P13">The day before imaging, i<sup>3</sup> neurons were stained with 1.5 μM SiR-lysosome and 10 μM verapamil hydrochloride solution and incubated overnight. On the day of imaging, cells were washed twice with the culture media. 10 μM verapamil hydrochloride solution was added again with fresh culture media.</p></sec><sec id="S11"><title>ER</title><p id="P14">mEmerald-KDEL lentivirus and ER-GCaMP6 lentivirus were added to i<sup>3</sup> neurons at 14-15 DIV to monitor the ER morphology and ER calcium level, respectively.</p></sec><sec id="S12"><title>Widefield microscopy</title><p id="P15">Widefield imaging was performed with an automated custom-built widefield microscope. 4-wavelength high-power LED source (LED4D067, Thorlabs), stage (Prior), frame (IX83, Olympus), Z drift compensator (IX3-ZDC2, Olympus) and an sCMOS camera (Zyla sCMOS, Andor) were controlled by Micro-Manager. Filter cubes for ER-GCaMP6 (filter set 49002-ET-EGFP, Chroma), calcium imaging or DQ-Red BSA (filter set 49008-ET-mCherry, Texas Red, Chroma) were used. For calcium imaging, ER-GCaMP6 or DQ-BSA assay, images were captured with a 10×/0.25 air (Plan N, Olympus), a 20×/0.45 NA air (LUCPlanFL N, Olympus), or a 60×/1.42 NA oil (PlanApo U, Olympus) objective lens, respectively. Live-cell images were captured while keeping the cells at 37°C with 0.5% CO2 atmosphere in a microscope stage top micro-incubator (OKO Lab).</p></sec><sec id="S13"><title>Structured illumination microscopy</title><p id="P16">The custom-made three-color SIM system was built on an Olympus IX71 microscope stage. Fluorophores were excited by lasers at the wavelengths of 488 nm (iBEAM-SMART-488, Toptica), 561 nm (OBIS 561, Coherent), or 640 nm (MLD 640, Cobolt). Structured illumination pattern was achieved by expanding the laser beam to fill the display of a ferroelectric binary Spatial Light Modulator (SLM) (SXGA-3DM, Forth Dimension Displays). A Pockels cell (M350-80-01, Conoptics) was used to control the polarisation of light. After focusing the structured illumination pattern onto the sample and collecting the emission light with a 60×/1.2 numerical aperture (NA) water immersion lens (UPLSAPO 60XW, Olympus), images were captured by a sCMOS camera (C11440, Hamamatsu). HCImage software (Hamamatsu) and a custom-made LabView program worked synchronously to acquire raw images. Live-cell SIM images were captured while keeping the cells on the OKO Lab stage. SIM images were reconstructed with LAG SIM, a custom-made ImageJ plugin after calibration of channel displacement with TetraSpeck beads (Life Technologies).</p></sec><sec id="S14"><title>Calcium imaging</title><p id="P17">Incucyte Neuroburst Orange lentivirus (Sartorius) was added to i<sup>3</sup> neurons at about 14-15 DIV with 2 μL/20,000 cells. From about 26 DIV, calcium imaging was performed with widefield microscopy which is described earlier in this section. Neurons (26-27 DIV) were treated for 4 days with 10 μM cholesterol, 10 μM 24S-HC, 10 μM 27-HC, 3 nM bafilomycin A1, 140 nM MG-132 or 2 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) after pretreatment imaging. The treatment was first added on Day 0 when the media was changed and replenished on Day 2 after imaging during the next media change to maintain consistent exposure. The same volume of DMSO or ethanol was added as vehicle control. Imaging was performed once daily over a period of five consecutive days. 1000 frames were captured with 3*3 binning, 100 ms exposure time and 0 intervals with an overall imaging time of 126 seconds.</p></sec><sec id="S15"><title>Seahorse Mito Stress Tests</title><p id="P18">10,000 cells per well of COS-7 cells were plated in the 96-well plate (XF96). 24 h after seeding, cells were treated with vehicle, 10 μM cholesterol, 10 μM 24S-HC or 10 μM 27-HC daily for two days. 1.5 μM oligomycin, 1 μM FCCP and 0.5 μM rotenone/antimycin A (Seahorse XF Cell Mito Stress Test Kit) were sequentially added to the cells during the oxygen consumption rates (OCR) measurement performed by a Seahorse XFe96 analyser (Agilent). Data were normalised to the cell number and analysed on Wave (Agilent). The spare respiratory capacity was calculated by subtracting the normalised OCR at time point 3 from time point 9.</p></sec><sec id="S16"><title>DQ-BSA assay</title><p id="P19">i<sup>3</sup> neurons transduced with mEmerald-KDEL lentivirus were stained with 10 μg/mL DQ Red BSA for 6 h, followed by washing with PBS twice. In the meantime, 0.5 μM bafilomycin A1 was added for 6 h as a negative control. i<sup>3</sup> neurons were imaged using widefield microscopy which is described earlier in this section while keeping the cells on the OKO Lab stage. Images were captured with an exposure time of 100 ms. To avoid photo bleaching, somas were focused with the ER channel followed by the capture of both channels. DQ-BSA assay data analysis was performed using imageJ. The ER channel was used to identify the soma by applying Otsu’s thresholding and using the “Analyse Particles” function in imageJ to get the region of interest (ROI). The DQ-BSA fluorescence intensity of the soma was measured by applying the saved ROI after subtracting the background noise.</p></sec><sec id="S17"><title>Expression and purification of <sup>15</sup>N-labelled recombinant aSyn for NMR studies</title><p id="P20">Recombinant aSyn was expressed in <italic>E. coli</italic> using the plasmid pT7-7 as previously described<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. In order to obtain N-terminal acetylation of aSyn, coexpression with a plasmid carrying the components of the NatB complex (Addgene) was used. After transforming into BL21-Gold (DE3) cells (Agilent Technologies), uniformly <sup>15</sup>N labelled aSyn was obtained by growing the bacteria in isotope-enriched M9 minimal media containing 1 g/L of <sup>15</sup>N ammonium chloride (Sigma-Aldrich) and 1 g/L of <sup>15</sup>N IsoGro (Sigma). Cell growth was performed at 37 °C under constant shaking at 250 rpm and using 100 μg/mL ampicillin. Upon reaching an OD600 of 0.6, aSyn expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 37 °C for 4 h, and subsequently cells were harvested by centrifugation at 6,200 x g (Beckman Coulter). Cell pellets were then resuspended in lysis buffer (10 mM Tris-HCl pH 8, 1 mM EDTA and EDTA-free complete protease inhibitor cocktail tablets (Roche) and lysed by sonication. The cell lysate was centrifuged at 22,000 x g for 30 minutes to remove cell debris. In order to precipitate heat-sensitive proteins, the supernatant was then heated for 20 minutes at 70 °C and centrifuged at 22,000 x g. Subsequently streptomycin sulfate was added to the supernatant to a final concentration of 10 mg/mL to stimulate DNA precipitation. The mixture was stirred for 15 minutes at 4 °C followed by centrifugation at 22,000 x g. Subsequently, ammonium sulfate was added to the supernatant to a concentration of 360 mg/mL in order to precipitate the protein, and the solution was then stirred for 30 minutes at 4 °C prior to further centrifugation at 22,000 x g. The resulting pellet was resuspended in 25 mM Tris-HCl, pH 7.7 and dialysed against the same buffer in order to remove salts. The dialysed solutions were then loaded onto an anion exchange column (26/10 Q sepharose high performance, GE Healthcare) and eluted with a 0–1 M NaCl step gradient, and then further purified by loading onto a size exclusion column (Hiload 26/60 Superdex 75 preparation grade, GE Healthcare). All the fractions containing the monomeric protein were pooled together and concentrated by using Vivaspin filter devices (Sartorius Stedim Biotech). The purity of the aliquots after each step was analysed by SDS-PAGE and the protein concentration was determined from the absorbance at 275 nm using an extinction coefficient of 5600 M<sup>-1</sup> cm<sup>-1</sup>. Mass spectrometry was used to assess that the level of N-terminal acetylation was complete.</p></sec><sec id="S18"><title>NMR</title><p id="P21">NMR experiments were carried out at 10 °C on a Bruker spectrometer operating at a <sup>1</sup>H frequency of 700 MHz equipped with triple resonance HCN cryo-probe, and data were collected using TopSpin 4.4.0 software (Bruker, AXS GmBH). The aSyn concentration was kept constant at 10 μM in all experiments. <sup>1</sup>H-<sup>15</sup>N HSQC spectra were recorded using a data matrix consisting of 2048 (t2, <sup>1</sup>H) × 220 (t1, 15N) complex points. Assignments of the resonances in <sup>1</sup>H-<sup>15</sup>N HSQC spectra of aSyn are derived from our previous studies, and data were analysed using Sparky 3.1 software.</p></sec></sec><sec id="S19"><title>Data analysis</title><sec id="S20"><title>Calcium imaging</title><p id="P22">The calcium imaging data were analysed using a custom Python script. Maximum intensity projection images were generated from time-series fluorescence images, followed by Otsu’s thresholding to create a binary mask. Individual somas were identified using rectangular bounding boxes applied to the binarized images, with adjustable size parameters to exclude clustered or improperly segmented regions. Raw calcium traces were extracted from each selected soma and normalised to ΔF/F<sub>0</sub> calculated using the formula: <disp-formula id="FD1"><mml:math id="M1"><mml:mrow><mml:mtext>Δ</mml:mtext><mml:mi>F</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mtext>F</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula> where F<sub>t</sub> is the fluorescence intensity at each time point, and F<sub>0</sub> represents the baseline fluorescence intensity, indicative of the resting calcium level. It is determined by averaging the fluorescence intensity over a designated time window in which no calcium spikes are observed, ensuring a stable baseline measurement. For each trace, relative calcium spike amplitudes (peak ΔF/F<sub>0</sub>) were computed by normalising to the baseline fluorescence intensity within the trace: <disp-formula id="FD2"><mml:math id="M2"><mml:mrow><mml:mi>peak</mml:mi><mml:mi>Δ</mml:mi><mml:mi>F</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mtext>F</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula> where F<sub>0</sub> is the baseline fluorescence intensity, and Fpeak is the peak fluorescence intensity. The number of detected peaks was counted and normalised by the total recording time to determine the spike rate (spikes per second). To quantify calcium spike synchronicity, we computed the Spike Time Tiling Coefficient (STTC), a metric designed to assess the temporal alignment of spike events between calcium traces<sup><xref ref-type="bibr" rid="R35">35</xref></sup>. For each pair of detected calcium traces, the STTC was calculated using a time window (±Δt) of 0.5 seconds. This metric compares the total proportion of recording time that falls within the time window around spikes in one trace to the proportion of spikes in another trace that also lie within that time window. The STTC is computed as follows: <disp-formula id="FD3"><mml:math id="M3"><mml:mrow><mml:mtext>STTC</mml:mtext><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>×</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>X</mml:mi><mml:mo>−</mml:mo><mml:mi>T</mml:mi><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>T</mml:mi><mml:mi>Y</mml:mi><mml:mo>*</mml:mo><mml:mi>P</mml:mi><mml:mi>X</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>Y</mml:mi><mml:mo>−</mml:mo><mml:mi>T</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>T</mml:mi><mml:mi>X</mml:mi><mml:mo>*</mml:mo><mml:mi>P</mml:mi><mml:mi>Y</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula> where PX and PY are the proportions of spikes in traces X and Y that fall within ±Δt of a spike in the other trace, and TX and TY represent the fraction of total recording time that lies within ±Δt of any spike in traces X and Y, respectively.</p></sec><sec id="S21"><title>Mitochondrial morphology</title><p id="P23">Mitochondrial morphology was analysed using ImageJ. To do the segmentation of mitochondria, Otsu’s thresholding was applied to each image, followed by the “Analyse Particles” function in imageJ with a size filter excluding objects smaller than 0.1 μm<sup>2</sup>. The circularity of each mitochondrion was calculated automatically by ImageJ using the formula: 4π(area/perimeter<sup>2</sup>). The value of circularity is ranged from 0 to 1, where 1 indicates a perfect circle.</p></sec><sec id="S22"><title>Lysosomal morphology</title><p id="P24">Lysosomal morphology was analysed using ImageJ. To do the segmentation of lysosomes, Otsu’s thresholding was applied to each image, followed by the “Analyse Particles” function in imageJ with a size filter excluding objects smaller than 0.1 μm<sup>2</sup>. The area of each lysosome was measured automatically by ImageJ. The number of neurons that have lysosomal dye leakage was counted manually.</p></sec><sec id="S23"><title>ER calcium</title><p id="P25">After subtracting the background noise, Otsu’s thresholding was applied to each image, followed by the “Analyse Particles” function in imageJ with a size filter to identify the somas. The ER-GCaMP6 fluorescence intensity was measured for each ROI.</p></sec><sec id="S24"><title>Statistical analysis</title><p id="P26">All statistical analysis was done using GraphPad Prism 8 or 10.</p></sec></sec></sec><sec id="S25" sec-type="results"><title>Results</title><sec id="S26"><title>24S-HC and 27-HC impair calcium signalling in i<sup>3</sup> neurons</title><p id="P27">We first investigated how 24S-HC and 27-HC affect neuronal function at the cellular level using human iPSC-derived i<sup>3</sup> neurons. To determine the optimal treatment concentration, we employed calcium imaging, as calcium signalling serves as a key indicator of neuronal function and activity. For this, i<sup>3</sup> neurons were transduced with the Incucyte Neuroburst Orange lentivirus, a cytosolic calcium indicator, and imaged using widefield microscopy at approximately day 26 in vitro (DIV), a time point characterised by spontaneous, synchronised calcium activity<sup><xref ref-type="bibr" rid="R36">36</xref></sup>, indicative of functional network maturation (<xref ref-type="supplementary-material" rid="SD1">Figure S1</xref>). Following baseline imaging, neurons were treated with 2.5, 5, or 10 μM of cholesterol, 24S-HC, or 27-HC for four days, and imaged daily over a five-day period. For each time-series of fluorescence images, individual somas were identified via thresholding to plot the cytosolic calcium traces, while clustered neurons were filtered out (<xref ref-type="fig" rid="F1">Figure 1a</xref>). Our results show that both 24S-HC and 27-HC impaired calcium signalling in a dose-dependent manner, whereas cholesterol did not exhibit a clear trend (<xref ref-type="supplementary-material" rid="SD1">Figures S2–S4</xref>). Based on these findings, we selected 10 μM for further experiments, as it produced a clear biological response without excessive cytotoxicity.</p><p id="P28">After one day of treatment, both 10 μM 24S-HC and 27-HC altered the calcium firing patterns in i<sup>3</sup> neurons compared to vehicle controls (<xref ref-type="fig" rid="F1">Figure 1b</xref>). These changes were characterised by a broadening of calcium spikes and elevated basal intracellular calcium levels. To further characterise these effects, we analysed calcium dynamics over a five-day period, including resting calcium levels, relative calcium spike amplitude, spike rate, and synchronicity. 27-HC significantly increased resting calcium levels (F<sub>0</sub>) after just one day of treatment, whereas the effect of 24S-HC emerged after two days and continued to increase progressively, indicating a sustained elevation in cytosolic calcium level (<xref ref-type="fig" rid="F1">Figure 1c</xref>). In parallel, 27-HC significantly reduced the relative calcium spike amplitude (peak ΔF/F<sub>0</sub>) after one day, with 24S-HC producing a comparable reduction after two days (<xref ref-type="fig" rid="F1">Figure 1d</xref>). These reductions worsened over time, reflecting a progressive dampening of intracellular calcium transients. Interestingly, 24S-HC transiently increased spike rate during the first two days, while 27-HC led to a significant decrease in spike rate from day three onwards (<xref ref-type="fig" rid="F1">Figure 1e</xref>). Although the temporal patterns differed, both oxysterols disrupted the normal frequency and regulation of calcium activity. Notably, both compounds significantly reduced calcium spike synchronicity from day one, with this effect becoming increasingly pronounced over time (<xref ref-type="fig" rid="F1">Figure 1f</xref>), suggesting impaired coordinated activity across neuronal networks. In contrast, cholesterol treatment did not produce consistent or significant changes in any of the measured calcium dynamics parameters (<xref ref-type="fig" rid="F1">Figure 1c–f</xref>), likely due to its limited membrane permeability compared to 24S-HC and 27-HC, both of which contain an additional hydroxyl group facilitating cellular uptake<sup>1</sup>. Together, these findings demonstrate that treatment with 10 μM 24S-HC and 27-HC leads to significant, progressive disruption of calcium homeostasis and network activity in i<sup>3</sup> neurons, highlighting their potential neurotoxic effects.</p><p id="P29">Several organelles are implicated in calcium homeostasis. To investigate which organelle/pathway is linked to the above observed calcium signalling effect, we treated the neurons with pharmacological inhibitors: 3 nM bafilomycin A1, 140 nM MG-132, and 2 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), effective concentrations without excessive cytotoxicity. Bafilomycin A1 is an autophagy inhibitor that disrupts V-ATPase-dependent acidification and Ca-P6OA/SERCA-mediated autophagosome-lysosome fusion<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. MG-132 inhibits the ubiquitin-proteasome system<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. FCCP is an uncoupler of oxidative phosphorylation in mitochondria, disrupting the proton gradient across the inner mitochondrial membrane, thereby reducing the driving force for ATP synthesis<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Our results show that treatment with 3 nM bafilomycin A1 for two days significantly increased resting calcium levels, whereas 2 μM FCCP led to a reduction (<xref ref-type="supplementary-material" rid="SD1">Figure S5a</xref>). In contrast, 140 nM MG-132 did not produce a significant effect on resting calcium levels. All three treatments affected the relative calcium spike amplitude: bafilomycin A1 and MG-132 induced reductions after three and two days, respectively, while FCCP caused a decrease after either one or three days of exposure (<xref ref-type="supplementary-material" rid="SD1">Figure S5b</xref>). Additionally, calcium spike rate was significantly reduced following two days of treatment with each inhibitor, with progressive worsening over subsequent days, except in the case of FCCP (<xref ref-type="supplementary-material" rid="SD1">Figure S5c</xref>). A loss of calcium spike synchronicity was also observed after three or four days of treatment with MG-132 and bafilomycin A1, while FCCP did not significantly affect synchronicity (<xref ref-type="supplementary-material" rid="SD1">Figure S5d</xref>). In summary, these findings indicate that disruption of lysosomal function, proteostasis, or mitochondrial activity can each contribute to impaired calcium signalling in i<sup>3</sup> neurons.</p></sec><sec id="S27"><title>24S-HC and 27-HC cause mitochondrial dysfunction</title><p id="P30">Previous experiments showed that 10 μM 24S-HC and 27-HC induced significant calcium signalling impairments within 1 day, with effects worsening over time. To capture a representative stage of this phenotype while ensuring experimental consistency, we selected a 3-day treatment duration for subsequent experiments. Given the similarity in reduced relative calcium spike amplitude observed with 24S/27-HC and FCCP, we investigated whether 24S-HC and 27-HC contribute to mitochondrial dysfunction. As an initial indicator of potential alterations, we assessed mitochondrial morphology in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC, or 27-HC for 3 days, using SIM. Compared to vehicle control, 24S-HC or 27-HC treatment induced mitochondrial fragmentation in i<sup>3</sup> neurons, while cholesterol had no significant impact (<xref ref-type="fig" rid="F2">Figure 2a</xref>). Quantitative analysis confirmed a significant increase in mitochondrial circularity with 24S-HC and 27-HC but not cholesterol (<xref ref-type="fig" rid="F2">Figure 2b</xref>). The same effect was also observed in COS-7 cells, the African green monkey kidney fibroblast-like cells, with 10 μM 24S-HC or 27-HC treatment for 1 day (<xref ref-type="supplementary-material" rid="SD1">Figure S6a and b</xref>), which we later use to run the Seahorse Mito Stress Test on.</p><p id="P31">Since structural changes often precede or accompany functional impairments, we assessed mitochondrial respiration using the Seahorse Mito Stress Tests. COS-7 cells were treated daily with 10 μM cholesterol, 24S-HC or 27-HC for two days, and the oxygen consumption rate (OCR) was measured upon the addition of oligomycin, FCCP and antimycin A and rotenone (<xref ref-type="fig" rid="F2">Figure 2c</xref>). After FCCP addition, the spare respiratory capacity was significantly reduced in COS-7 cells treated with 24S-HC or 27-HC, but not with cholesterol, compared to vehicle control (<xref ref-type="fig" rid="F2">Figure 2d</xref>), indicating impaired mitochondrial respiration. Collectively, these results show that 24S-HC and 27-HC induce mitochondrial dysfunction in i<sup>3</sup> neurons and COS-7 cells.</p></sec><sec id="S28"><title>24S-HC and 27-HC cause lysosomal dysfunction in i<sup>3</sup> neurons</title><p id="P32">Since 24S-HC, 27-HC and bafilomycin A1 induced similar calcium signalling defects, we next investigated whether 24S-HC and 27-HC affect lysosomal function. Using SIM, we examined lysosomal morphology in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC, or 27-HC for 3 days. U18666A, a drug that induces cholesterol accumulation in lysosomes and mimics Niemann-Pick disease type C (NPC), was used as a positive control<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. Mitochondria were co-stained to identify somas. We found that 27-HC caused an enlargement of somatic lysosomes in i<sup>3</sup> neurons, while neither cholesterol nor 24S-HC had a similar effect (<xref ref-type="fig" rid="F3">Figure 3a</xref>). Quantification results further proved this, showing an increased lysosome size upon treatment with 27-HC (<xref ref-type="fig" rid="F3">Figure 3b</xref>). The same effect was also observed in COS-7 cells (<xref ref-type="supplementary-material" rid="SD1">Figure S6c and d</xref>). Notably, 27-HC not only enlarged lysosomes but also induced lysosomal membrane permeabilisation (LMP), as evidenced by leakage of the lysosomal labelling dye (<xref ref-type="fig" rid="F3">Figure 3c</xref>, orange arrows). The fluorescent traces likely reflect the trajectory of lysosome movement, as the leakage occurred while lysosomes were actively trafficking within the cell. Quantification results show that 76% of i<sup>3</sup> neurons treated with 27-HC exhibited dye leakage, a phenomenon not observed in any other treatment conditions (<xref ref-type="fig" rid="F3">Figure 3d</xref>).</p><p id="P33">To determine whether LMP leads to lysosomal dysfunction, we performed the DQ-BSA (dye quenched-bovine serum albumin) assay. In this assay, BODIPY-conjugated BSA remains self-quenched until lysosomal degradation of BSA releases the dye from its quenched state. i<sup>3</sup> neurons were treated with 10 μM cholesterol, 24S-HC, or 27-HC for 3 days, with 0.5 μM bafilomycin A1 added for 6 h as a negative control. ER was labelled by transducing neurons with an mEmerald-KDEL lentivirus to identify the soma. Representative widefield images show markedly reduced fluorescence intensity in i<sup>3</sup> neurons treated with 24S-HC and 27-HC, but not with cholesterol, compared to vehicle control (<xref ref-type="fig" rid="F3">Figure 3e</xref>). Quantitative analysis confirmed a significant decrease in fluorescence intensity (<xref ref-type="fig" rid="F3">Figure 3f</xref>), indicating impaired lysosomal degradation capacity. Together, these findings demonstrate that 24S-HC and 27-HC induce lysosomal dysfunction in i<sup>3</sup> neurons.</p></sec><sec id="S29"><title>24S-HC and 27-HC cause ER disturbances in i<sup>3</sup> neurons</title><p id="P34">Since lysosomes regulate the tubular distribution of the ER<sup><xref ref-type="bibr" rid="R41">41</xref></sup>, the observed lysosomal impairment may contribute to ER dysfunction. To investigate this, i<sup>3</sup> neurons were treated with 10 μM cholesterol, 24S-HC, or 27-HC for 3 days, and the ER, mitochondria, and lysosomes in axons near the soma were imaged using SIM. With 24S-HC and 27-HC treatment, ER structures appeared constricted and displaced in swellings of axonal regions, colocalised with enlarged mitochondria but not with lysosomes (<xref ref-type="fig" rid="F4">Figure 4a</xref>, orange arrows). Quantification revealed a 4-to-5-fold increase in the number of swellings in axons with 24S-HC and 27-HC treatment compared to vehicle control and cholesterol-treated conditions (<xref ref-type="fig" rid="F4">Figure 4b</xref>), suggesting that while axonal swelling may occur physiologically, it is markedly exacerbated under pathological conditions.</p><p id="P35">The ER is central to neuronal calcium homeostasis, regulating calcium storage and release, particularly during neuronal activity<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. To assess ER calcium levels, i<sup>3</sup> neurons were transduced with an ER-GCaMP6 lentivirus and imaged using widefield microscopy (<xref ref-type="fig" rid="F4">Figure 4c</xref>). Quantification shows significantly higher ER-GCaMP6 fluorescence intensity in the soma of i<sup>3</sup> neurons treated with 24S-HC and 27-HC, but not with cholesterol, compared to vehicle control (<xref ref-type="fig" rid="F4">Figure 4d</xref>), indicating elevated ER calcium levels. Together, these findings demonstrate that 24S-HC and 27-HC induce ER disturbances in i<sup>3</sup> neurons.</p></sec><sec id="S30"><title>24S-HC and 27-HC bind directly to the N-terminus of aSyn with greater affinity than cholesterol</title><p id="P36">To further explore the connection between oxysterols and neurodegeneration, we investigated their role in the context of PD, a well-characterised neurodegenerative disorder marked by aSyn pathology. Previous studies have shown that both 24S-HC and 27-HC promote aSyn aggregation, as demonstrated by thioflavin T (ThT) fluorescence assays and cellular models<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. Furthermore, cholesterol has previously been shown to directly interact with aSyn<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. To further investigate whether the cholesterol metabolites 24S-HC and 27-HC also engage in direct interactions with aSyn, we performed nuclear magnetic resonance (NMR) spectroscopy. Our results reveal that both 24S-HC and 27-HC bind directly to the N-terminal region of aSyn, exhibiting significantly greater affinity than cholesterol (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p><p id="P37">To examine the functional consequences of this interaction in a cellular context, we utilised SH-SY5Y neuroblastoma cells overexpressing aSyn-YFP. Cells were treated with 10 μM cholesterol, 24S-HC, or 27-HC for 2 days to assess their impact on aSyn levels. Our results show significantly increased YFP fluorescence intensity in cells treated with 24S-HC or 27-HC, but not with cholesterol, compared to vehicle control (<xref ref-type="supplementary-material" rid="SD1">Figure S7</xref>), suggesting that these oxysterols directly increase intracellular aSyn levels.</p><p id="P38">To finally confirm that the different cholesterol/metabolites are indeed taken up by neurons and to test whether their interaction with aSyn influences cholesterol metabolism, we performed a sterolomic analysis. Primary hippocampal neurons were treated with 10 μM 24S-HC or 27-HC, in the presence or absence of 500 nM extracellular aSyn, a concentration within the physiological range<sup><xref ref-type="bibr" rid="R43">43</xref></sup>. Sterolomic analysis revealed elevated intracellular levels of 24S-HC and 27-HC compared to vehicle-treated controls, indicating efficient cellular uptake of these oxysterols (<xref ref-type="supplementary-material" rid="SD1">Figure S8a and d</xref>). This was further supported by the increased abundance of their downstream metabolites (<xref ref-type="supplementary-material" rid="SD1">Figure S8b, c, e and f</xref>), suggesting active intracellular metabolism. Notably, the presence of extracellular aSyn led to an increase in the downstream metabolite of 24-HC, namely 7α,24-dihydroxycholest-4-en-3-one (7α,24-diHCO), but a modest reduction in 24S-HC itself and another downstream metabolite 7α,24-dihydroxycholesterol (7α,24-diHC) (<xref ref-type="supplementary-material" rid="SD1">Figure S8a, b and c</xref>). In contrast, extracellular aSyn enhanced the accumulation of 27-HC and its downstream metabolites, 7α,27-dihydroxycholesterol (7α,27-diHC) and 7α,27-dihydroxycholest-4-en-3-one (7α,27-diHCO)<sup><xref ref-type="bibr" rid="R44">44</xref></sup> (<xref ref-type="supplementary-material" rid="SD1">Figure S8d, e, and f</xref>), suggesting that aSyn may facilitate the cellular uptake and metabolic processing of both 24S-HC and 27-HC, though with different magnitudes. Together, these findings support a direct molecular link between dysregulated cholesterol metabolism, aSyn pathology, and the progression of PD.</p></sec></sec><sec id="S31" sec-type="discussion"><title>Discussion</title><p id="P39">Neurodegenerative diseases are characterised by a progressive disruption of normal neuronal function, beginning with impaired synaptic transmission<sup><xref ref-type="bibr" rid="R45">45</xref></sup> and culminating in a loss of synchronous neuronal firing. Given this trajectory, calcium signalling serves as a powerful readout for assessing the effects of cholesterol and its metabolites on neuronal function. Calcium dynamics are essential for synaptic plasticity and neurotransmitter release<sup><xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>, and are precisely regulated by a balance of cytosolic influx, efflux, and exchange with internal stores such as the ER and mitochondria<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Perturbations in this tightly controlled system can disrupt synaptic integrity and are increasingly recognised as contributing factors in the pathogenesis of neurodegenerative diseases<sup><xref ref-type="bibr" rid="R46">46</xref></sup>. Our study shows that 24S-HC and 27-HC dysregulate calcium dynamics in i<sup>3</sup> neurons. Calcium imaging heatmaps revealed a broadening of calcium spikes following one day of treatment with 24S-HC and 27-HC, indicative of prolonged intracellular calcium elevations. Interestingly, increased dendritic calcium transient duration during activity behaviour has also been observed in APP/PS1 mice<sup><xref ref-type="bibr" rid="R47">47</xref></sup>. Additionally, both metabolites increased resting cytosolic calcium levels, consistent with previous findings in SK-N-BE and SH-SY5Y cells treated with these oxysterols<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup>. Elevated cytosolic calcium level is a hallmark of several neurodegenerative diseases, including PD and AD<sup><xref ref-type="bibr" rid="R50">50</xref></sup>. For example, mutant aSyn and Aβ oligomers elevate cytosolic calcium by increasing plasma membrane ion permeability<sup><xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref></sup>. In our experiments, 24S-HC and 27-HC also decreased relative calcium spike amplitude, suggesting impaired calcium fluctuations, and inhibition or overactivation of calcium channels or transporters such as voltage-gated calcium channels and ryanodine receptors.</p><p id="P40">Following oxysterol treatment, we also observed elevated ER calcium levels in neuronal somas, paralleling reports of ER calcium overload in GBA1-linked PD fibroblasts<sup><xref ref-type="bibr" rid="R53">53</xref></sup> and in familial AD due to presenilin mutations<sup><xref ref-type="bibr" rid="R54">54</xref></sup>. Since mitochondria sequester calcium from the ER at mitochondria-associated membranes (MAMs), ER calcium overload may propagate mitochondrial calcium stress, potentially inducing apoptosis or autophagy<sup><xref ref-type="bibr" rid="R55">55</xref></sup>. Additionally, 24S-HC and 27-HC altered calcium spike rate, although without a clear pattern, consistent with biphasic calcium spike rate changes seen in PD models<sup><xref ref-type="bibr" rid="R56">56</xref></sup>.</p><p id="P41">Our data further reveal an impaired calcium spike synchronisation, a feature critical for spike timing-dependent plasticity<sup><xref ref-type="bibr" rid="R57">57</xref></sup> and particularly vital in the substantia nigra’s dopaminergic neurons, which exhibit regular calcium spikes and are highly sensitive to calcium overload<sup><xref ref-type="bibr" rid="R58">58</xref></sup>. Our findings thus suggest that 24S-HC and 27-HC significantly compromise neuronal network function by impairing both intracellular and intercellular calcium signalling.</p><p id="P42">Calcium homeostasis is tightly regulated by multiple intracellular organelles, including mitochondria, lysosomes, and the ER, all of which are known to be disrupted in neurodegenerative diseases. As such, organelle dysfunction may play a direct role in calcium dysregulation. To identify which organelle pathways could underlie the calcium signalling defects observed in our system, we treated i<sup>3</sup> neurons with bafilomycin A1, MG-132, and FCCP, targeting lysosomes, the proteasome, and mitochondria, respectively. Each compound induced measurable alterations in calcium dynamics, underscoring the critical role of organelle function in maintaining calcium homeostasis. These results prompted a more detailed investigation into the specific contribution of each organelle to the observed calcium signalling defects.</p><p id="P43">We found that 24S-HC and 27-HC induce mitochondrial fragmentation in axons and dendrites, visualised through SIM. Mitochondrial dynamics, regulated by fission (Drp1) and fusion proteins (Mfn1, Mfn2, OPA1), are critical for neuronal energy demands<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>. Our findings suggest a shift toward fission, potentially disrupting synaptic density<sup><xref ref-type="bibr" rid="R61">61</xref></sup> and transmission<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. Similar mechanisms have been implicated in PD and AD through PINK1/LRRK2 mutations<sup><xref ref-type="bibr" rid="R63">63</xref></sup> and altered Drp1 activity<sup><xref ref-type="bibr" rid="R64">64</xref></sup>.</p><p id="P44">Mitochondrial fragmentation also correlates with reduced membrane potential (ΔΨm) and increased reactive oxygen species (ROS), both seen in neurodegeneration<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. Previous studies report that 24S-HC and 27-HC reduce ΔΨm<sup><xref ref-type="bibr" rid="R65">65</xref>–<xref ref-type="bibr" rid="R67">67</xref></sup> and increase ROS<sup><xref ref-type="bibr" rid="R67">67</xref>–<xref ref-type="bibr" rid="R70">70</xref></sup>. We confirmed reduced spare respiratory capacity using the Seahorse Mito Stress Test, indicating mitochondrial dysfunction<sup><xref ref-type="bibr" rid="R71">71</xref>,<xref ref-type="bibr" rid="R72">72</xref></sup>—a severe threat to ATP-dependent neuronal processes, as highlighted by the defect to calcium signalling in i<sup>3</sup> neurons upon oxysterol treatment.</p><p id="P45">Lysosomal dysfunction was evident following 27-HC treatment, which induced lysosomal enlargement and LMP, consistent with cathepsins leakage observed in murine myeloid immune cells and co-cultured SH-SY5Y cells and C6 cells<sup><xref ref-type="bibr" rid="R67">67</xref>,<xref ref-type="bibr" rid="R73">73</xref></sup>. These structural changes may reduce lysosomal mobility<sup><xref ref-type="bibr" rid="R74">74</xref></sup> and function, impairing degradation and organelle clearance. Using the DQ-BSA assay, we found that both oxysterols reduced lysosomal degradation, which could impair mitophagy and exacerbate mitochondrial defects. These findings parallel disruptions in PINK1/Parkin-dependent mitophagy observed in PD<sup><xref ref-type="bibr" rid="R75">75</xref>,<xref ref-type="bibr" rid="R76">76</xref></sup>.</p><p id="P46">Lysosomes also regulate calcium storage and release<sup><xref ref-type="bibr" rid="R77">77</xref></sup>. LMP and reduced lysosomal acidification may cause unregulated calcium release<sup><xref ref-type="bibr" rid="R78">78</xref></sup>, potentially contributing to the calcium dysregulation observed. This was further supported by the observation that bafilomycin A1 induced calcium defects similar to those caused by oxysterol treatment<sup><xref ref-type="bibr" rid="R79">79</xref></sup>. Similarly, in GBA1 mutant fibroblasts and NPC1 disease, lysosomal calcium storage is impaired<sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R80">80</xref></sup>, linking degradation deficits to calcium imbalance.</p><p id="P47">We also observed axonal swelling and disrupted ER-mitochondria interactions. Axonal swelling colocalised with enlarged mitochondria, suggesting compression of the tubular ER within axons. As the axonal ER is key for calcium buffering and neurotransmitter release<sup><xref ref-type="bibr" rid="R81">81</xref>,<xref ref-type="bibr" rid="R82">82</xref></sup>, such disruptions may promote synaptic and axonal degeneration<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R83">83</xref></sup>. Mitochondrial swelling may also underlie impaired MAM and calcium dysregulation. Prior studies link aSyn and DJ-1 mutations in PD to disrupted MAM integrity<sup><xref ref-type="bibr" rid="R84">84</xref>,<xref ref-type="bibr" rid="R85">85</xref></sup>, and 24S-HC esters have been shown to disrupt ER membranes in SH-SY5Y cells<sup><xref ref-type="bibr" rid="R86">86</xref></sup>. Future experiments measuring the ubiquitin-proteasome system activity and analysing MAMs using MAM-specific markers will be essential for validating these effects.</p><p id="P48">It is challenging to identify a single organelle as the primary cause of the calcium signalling defects we have observed. However, the elevated calcium concentrations seen across all oxysterol treatments are most closely replicated by bafilomycin A1 treatment. This is particularly noteworthy given that PD has also been characterised as a lysosomal storage disorder<sup><xref ref-type="bibr" rid="R87">87</xref></sup>. Lysosomes appear to play a central role in regulating the function and fate of multiple organelles, including mitochondria and the ER<sup><xref ref-type="bibr" rid="R88">88</xref>–<xref ref-type="bibr" rid="R90">90</xref></sup>, especially the tubular ER, which is the predominant ER form in axons. Our recent findings demonstrate that the tubular ER network is shaped and extended through the movement of lysosomes trafficked along microtubules<sup><xref ref-type="bibr" rid="R41">41</xref></sup>. Therefore, lysosomal enlargement and impaired trafficking to the periphery of the cells may disrupt the organisation of the tubular ER in axons, which in turn could impact mitochondrial fission and fusion<sup><xref ref-type="bibr" rid="R91">91</xref></sup>. Such disturbances may compromise the delivery of essential trophic factors, such as proteins, calcium, and lipids, to synapses<sup><xref ref-type="bibr" rid="R92">92</xref></sup>. Further experiments will be necessary to investigate these mechanisms in greater detail and to clarify the interdependence of these organelles in the context of oxysterol-induced dysfunction.</p><p id="P49">As an initial step toward exploring the connection between oxysterols and PD, we examined the molecular interactions between 24S-hydroxycholesterol (24S-HC), 27-hydroxycholesterol (27-HC), and alpha-synuclein (aSyn).This builds on previous studies suggesting that oxysterols can promote aSyn accumulation and aggregation, as well as earlier NMR findings indicating direct interactions between aSyn and cholesterol<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Our NMR analysis revealed that both 24S-HC and 27-HC bind specifically to the N-terminal region of aSyn with greater affinity than cholesterol. This higher binding affinity may enhance local aSyn concentration and promote conditions conducive to aggregation, thereby providing a potential molecular mechanism linking oxysterol accumulation to aSyn pathology in PD. This is further supported by experiments in SH-SY5Y cells overexpressing aSyn-YFP, where treatment with either oxysterol elevated aSyn-YFP levels. Whether this effect stems from direct molecular binding or results from transcriptional or translational upregulation remains to be clarified.</p><p id="P50">Additional evidence supporting a direct interaction comes from sterolomic analysis in primary neurons, where extracellular aSyn increased intracellular levels of 27-HC and its metabolites, 7α,27-diHC and 7α,27-diHCO. Interestingly, this aSyn-driven accumulation of 7α,27-diHC in neurons may correspond to the elevated levels of the same metabolite observed in the CSF of PD patients<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. An increase in the terminal metabolite 7α,24-diHCO was also observed, accompanied by a modest reduction in 24S-HC and 7α,24-diHC. These findings point to a potential feedforward loop in which elevated 24S-HC and 27-HC levels promote aSyn uptake and aggregation, while accumulated aSyn enhances oxysterol internalisation, amplifying pathological interactions relevant to PD.</p><p id="P51">Despite these findings, several critical questions remain unresolved. Do 24S-HC and 27-HC preferentially bind to specific aSyn conformers or influence distinct aggregation pathways? Could these oxysterols alter aSyn’s membrane- or vesicle-binding properties in a manner that promotes its pathological accumulation? Additionally, might they compromise membrane integrity or interfere with intracellular trafficking, thereby facilitating increased uptake or mislocalisation of aSyn? It also remains unclear whether similar mechanisms apply to other amyloidogenic proteins, such as Aβ. Further studies are needed to elucidate these pathways and determine whether oxysterol–protein interactions play a direct and causative role in the pathogenesis of PD and other neurodegenerative disorders.</p></sec><sec id="S32" sec-type="conclusions"><title>Conclusion</title><p id="P52">In conclusion, our findings uncover a previously underappreciated role for cholesterol metabolites in initiating and perpetuating a cascade of cellular dysfunction that spans calcium signalling, mitochondrial integrity, lysosomal capacity, and ER homeostasis. The convergence of these disruptions suggests that oxysterols act as central mediators of organelle crosstalk failure, amplifying neuronal stress through a self-reinforcing cycle of dysfunction. Coupled with their capacity to promote protein aggregation, 24S-HC and 27-HC emerge as potent contributors to neurodegenerative pathology. These insights position cholesterol metabolites not merely as bystanders, but as active drivers of disease progression. Targeting their accumulation or downstream effects may therefore offer a novel and urgently needed therapeutic avenue for halting or reversing neurodegeneration.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Information</label><media xlink:href="EMS206431-supplement-Supplementary_Information.pdf" mimetype="application" mime-subtype="pdf" id="d108aAcFbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S33"><title>Acknowledgements</title><p>G.S.K.S. acknowledges funding from the Wellcome Trust (065807/Z/01/Z and 203249/Z/16/Z), the UK Medical Re-search Council (MRC) (MR/K02292X/1), Alzheimer Research UK (ARUK-PG013-14), Michael J Fox Foundation (16238 and 022159), and Infinitus China Ltd. C.F.K. acknowledges funding from the UK Engineering and Physical Sciences Re-search Council (EPSRC) (EP/L015889/1 and EP/H018301/1), the Wellcome Trust (3-3249/Z/16/Z and 089703/Z/09/Z), the MRC (MR/K015850/1), and Infinitus China Ltd. Y.W. and W.G. acknowledge funding from UKRI MR/X012387/1 and BB/S019588/1.</p></ack><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björkhem</surname><given-names>I</given-names></name><name><surname>Meaney</surname><given-names>S</given-names></name></person-group><article-title>Brain Cholesterol: Long Secret Life Behind a Barrier</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>806</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">14764421</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yutuc</surname><given-names>E</given-names></name><etal/></person-group><article-title>Localization of sterols and oxy sterols in mouse brain reveals distinct spatial cholesterol metabolism</article-title><source>Proc Natl Acad Sci</source><year>2020</year><volume>117</volume><fpage>5749</fpage><lpage>5760</lpage><pub-id pub-id-type="pmcid">PMC7084107</pub-id><pub-id pub-id-type="pmid">32132201</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1917421117</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björkhem</surname><given-names>I</given-names></name></person-group><article-title>Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain</article-title><source>J Intern Med</source><year>2006</year><volume>260</volume><fpage>493</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">17116000</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czuba</surname><given-names>E</given-names></name><name><surname>Steliga</surname><given-names>A</given-names></name><name><surname>Lietzau</surname><given-names>G</given-names></name><name><surname>Kowiański</surname><given-names>P</given-names></name></person-group><article-title>Cholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions</article-title><source>Metab Brain Dis</source><year>2017</year><volume>32</volume><fpage>935</fpage><lpage>948</lpage><pub-id pub-id-type="pmcid">PMC5504126</pub-id><pub-id pub-id-type="pmid">28432486</pub-id><pub-id pub-id-type="doi">10.1007/s11011-017-0015-3</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>DMO</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><article-title>Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain</article-title><source>J Comp Neurol</source><year>2008</year><volume>507</volume><fpage>1676</fpage><lpage>1693</lpage><pub-id pub-id-type="pmcid">PMC4015140</pub-id><pub-id pub-id-type="pmid">18241055</pub-id><pub-id pub-id-type="doi">10.1002/cne.21605</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heverin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain</article-title><source>J Lipid Res</source><year>2005</year><volume>46</volume><fpage>1047</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">15741649</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Muneton</surname><given-names>S</given-names></name><name><surname>Sjövall</surname><given-names>J</given-names></name><name><surname>Jovanovic</surname><given-names>JN</given-names></name><name><surname>Griffiths</surname><given-names>WJ</given-names></name></person-group><article-title>The Effect of 24S-Hydroxycholesterol on Cholesterol Homeostasis in Neurons: Quantitative Changes to the Cortical Neuron Proteome</article-title><source>J Proteome Res</source><year>2008</year><volume>7</volume><fpage>1606</fpage><lpage>1614</lpage><pub-id pub-id-type="pmcid">PMC2374888</pub-id><pub-id pub-id-type="pmid">18303831</pub-id><pub-id pub-id-type="doi">10.1021/pr7006076</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>X</given-names></name><etal/></person-group><article-title>27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells*</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>38378</fpage><lpage>38387</lpage><pub-id pub-id-type="pmid">11504730</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Tong</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><article-title>Brain cholesterol homeostasis and its association with neurodegenerative diseases</article-title><source>Neurochem Int</source><year>2023</year><volume>171</volume><elocation-id>105635</elocation-id><pub-id pub-id-type="pmid">37949118</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets</article-title><source>Mol Neurobiol</source><year>2021</year><volume>58</volume><fpage>2183</fpage><lpage>2201</lpage><pub-id pub-id-type="pmid">33411241</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>TM</given-names></name><name><surname>Rosano</surname><given-names>C</given-names></name><name><surname>Evans</surname><given-names>RW</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name></person-group><article-title>Brain Cholesterol Metabolism, Oxysterols, and Dementia</article-title><source>J Alzheimers Dis JAD</source><year>2013</year><volume>33</volume><fpage>891</fpage><pub-id pub-id-type="pmcid">PMC4354887</pub-id><pub-id pub-id-type="pmid">23076077</pub-id><pub-id pub-id-type="doi">10.3233/JAD-2012-121585</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>SW</given-names></name><name><surname>Dykes</surname><given-names>AC</given-names></name><name><surname>Schreurs</surname><given-names>BG</given-names></name></person-group><article-title>A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus</article-title><source>J Alzheimers Dis JAD</source><year>2017</year><volume>56</volume><fpage>185</fpage><lpage>196</lpage><pub-id pub-id-type="pmcid">PMC5382498</pub-id><pub-id pub-id-type="pmid">27911307</pub-id><pub-id pub-id-type="doi">10.3233/JAD-160725</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats</article-title><source>Mol Nutr Food Res</source><year>2018</year><volume>62</volume><elocation-id>1700531</elocation-id><pub-id pub-id-type="pmid">29193679</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname><given-names>EG</given-names></name><name><surname>Aburto</surname><given-names>MR</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>O’Driscoll</surname><given-names>CM</given-names></name></person-group><article-title>The bloodbrain barrier in aging and neurodegeneration</article-title><source>Mol Psychiatry</source><year>2022</year><volume>27</volume><fpage>2659</fpage><lpage>2673</lpage><pub-id pub-id-type="pmcid">PMC9156404</pub-id><pub-id pub-id-type="pmid">35361905</pub-id><pub-id pub-id-type="doi">10.1038/s41380-022-01511-z</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björkhem</surname><given-names>I</given-names></name><etal/></person-group><article-title>Oxysterols and Parkinson’s disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease</article-title><source>Neurosci Lett</source><year>2013</year><volume>555</volume><fpage>102</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">24035896</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leoni</surname><given-names>V</given-names></name><name><surname>Caccia</surname><given-names>C</given-names></name></person-group><article-title>Oxysterols as biomarkers in neurodegenerative diseases</article-title><source>Chem Phys Lipids</source><year>2011</year><volume>164</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">21515244</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schönknecht</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer’s disease compared to healthy controls</article-title><source>Neurosci Lett</source><year>2002</year><volume>324</volume><fpage>83</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">11983301</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papassotiropoulos</surname><given-names>A</given-names></name><etal/></person-group><article-title>24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia</article-title><source>J Psychiatr Res</source><year>2002</year><volume>36</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11755458</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features</article-title><source>Front Aging Neurosci</source><year>2021</year><volume>13</volume><elocation-id>685594</elocation-id><pub-id pub-id-type="pmcid">PMC8435905</pub-id><pub-id pub-id-type="pmid">34526889</pub-id><pub-id pub-id-type="doi">10.3389/fnagi.2021.685594</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>L</given-names></name><etal/></person-group><article-title>The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson’s disease</article-title><source>PLOSBiol</source><year>2025</year><volume>23</volume><elocation-id>e3002974</elocation-id><pub-id pub-id-type="pmcid">PMC11835240</pub-id><pub-id pub-id-type="pmid">39964974</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002974</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>L</given-names></name><etal/></person-group><article-title>27-Hydroxycholesterol Drives the Spread of α-Synuclein Pathology in Parkinson’s Disease</article-title><source>Mov Disord</source><year>2023</year><volume>38</volume><fpage>2005</fpage><lpage>2018</lpage><pub-id pub-id-type="pmid">37593929</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasanthi</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on β-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells</article-title><source>Mol Neurodegener</source><year>2009</year><volume>4</volume><fpage>1</fpage><pub-id pub-id-type="pmcid">PMC2654562</pub-id><pub-id pub-id-type="pmid">19126211</pub-id><pub-id pub-id-type="doi">10.1186/1750-1326-4-1</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><etal/></person-group><article-title>High cholesterol and 27-hydroxycholesterol contribute to phosphorylation of tau protein by impairing autophagy causing learning and memory impairment in C57BL/6J mice</article-title><source>J Nutr Biochem</source><year>2022</year><volume>106</volume><elocation-id>109016</elocation-id><pub-id pub-id-type="pmid">35447319</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brini</surname><given-names>M</given-names></name><name><surname>Calì</surname><given-names>T</given-names></name><name><surname>Ottolini</surname><given-names>D</given-names></name><name><surname>Carafoli</surname><given-names>E</given-names></name></person-group><article-title>Neuronal calcium signaling: function and dysfunction</article-title><source>Cell Mol Life Sci</source><year>2014</year><volume>71</volume><fpage>2787</fpage><lpage>2814</lpage><pub-id pub-id-type="pmcid">PMC11113927</pub-id><pub-id pub-id-type="pmid">24442513</pub-id><pub-id pub-id-type="doi">10.1007/s00018-013-1550-7</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Sakaba</surname><given-names>T</given-names></name></person-group><article-title>Multiple Roles of Calcium Ions in the Regulation of Neurotransmitter Release</article-title><source>Neuron</source><year>2008</year><volume>59</volume><fpage>861</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">18817727</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>MJ</given-names></name></person-group><article-title>Neuronal Calcium Signaling</article-title><source>Neuron</source><year>1998</year><volume>21</volume><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">9697848</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grienberger</surname><given-names>C</given-names></name><name><surname>Konnerth</surname><given-names>A</given-names></name></person-group><article-title>Imaging Calcium in Neurons</article-title><source>Neuron</source><year>2012</year><volume>73</volume><fpage>862</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">22405199</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raffaello</surname><given-names>A</given-names></name><name><surname>Mammucari</surname><given-names>C</given-names></name><name><surname>Gherardi</surname><given-names>G</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name></person-group><article-title>Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria and lysosomes</article-title><source>Trends Biochem Sci</source><year>2016</year><volume>41</volume><fpage>1035</fpage><lpage>1049</lpage><pub-id pub-id-type="pmcid">PMC5123979</pub-id><pub-id pub-id-type="pmid">27692849</pub-id><pub-id pub-id-type="doi">10.1016/j.tibs.2016.09.001</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johri</surname><given-names>A</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondrial Dysfunction in Neurodegenerative Diseases</article-title><source>J Pharmacol Exp Ther</source><year>2012</year><volume>342</volume><fpage>619</fpage><lpage>630</lpage><pub-id pub-id-type="pmcid">PMC3422529</pub-id><pub-id pub-id-type="pmid">22700435</pub-id><pub-id pub-id-type="doi">10.1124/jpet.112.192138</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udayar</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sidransky</surname><given-names>E</given-names></name><name><surname>Jagasia</surname><given-names>R</given-names></name></person-group><article-title>Lysosomal dysfunction in neurodegeneration: emerging concepts and methods</article-title><source>Trends Neurosci</source><year>2022</year><volume>45</volume><fpage>184</fpage><pub-id pub-id-type="pmcid">PMC8854344</pub-id><pub-id pub-id-type="pmid">35034773</pub-id><pub-id pub-id-type="doi">10.1016/j.tins.2021.12.004</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Öztürk</surname><given-names>Z</given-names></name><name><surname>O’Kane</surname><given-names>CJ</given-names></name><name><surname>Pérez-Moreno</surname><given-names>JJ</given-names></name></person-group><article-title>Axonal Endoplasmic Reticulum Dynamics and Its Roles in Neurodegeneration</article-title><source>Front Neurosci</source><year>2020</year><volume>14</volume><pub-id pub-id-type="pmcid">PMC7025499</pub-id><pub-id pub-id-type="pmid">32116502</pub-id><pub-id pub-id-type="doi">10.3389/fnins.2020.00048</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandopulle</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons</article-title><source>Curr Protoc Cell Biol</source><year>2018</year><volume>79</volume><elocation-id>e51</elocation-id><pub-id pub-id-type="pmcid">PMC6993937</pub-id><pub-id pub-id-type="pmid">29924488</pub-id><pub-id pub-id-type="doi">10.1002/cpcb.51</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>WK</given-names></name><etal/></person-group><article-title>A Role of Cholesterol in Modulating the Binding of α-Synuclein to Synaptic-Like Vesicles</article-title><source>Front Neurosci</source><year>2020</year><volume>14</volume><fpage>18</fpage><pub-id pub-id-type="pmcid">PMC7000551</pub-id><pub-id pub-id-type="pmid">32063829</pub-id><pub-id pub-id-type="doi">10.3389/fnins.2020.00018</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Structure−Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates</article-title><source>J Am Chem Soc</source><year>2024</year><volume>146</volume><fpage>10537</fpage><lpage>10549</lpage><pub-id pub-id-type="pmcid">PMC11027145</pub-id><pub-id pub-id-type="pmid">38567991</pub-id><pub-id pub-id-type="doi">10.1021/jacs.3c14703</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutts</surname><given-names>CS</given-names></name><name><surname>Eglen</surname><given-names>SJ</given-names></name></person-group><article-title>Detecting Pairwise Correlations in Spike Trains: An Objective Comparison of Methods and Application to the Study of Retinal Waves</article-title><source>J Neurosci</source><year>2014</year><volume>34</volume><fpage>14288</fpage><lpage>14303</lpage><pub-id pub-id-type="pmcid">PMC4205553</pub-id><pub-id pub-id-type="pmid">25339742</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2767-14.2014</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>T</given-names></name><etal/></person-group><article-title>Endoplasmic reticulum morphology regulation by RTN4 modulates neuronal regeneration by curbing luminal transport</article-title><source>Cell Rep</source><year>2024</year><volume>43</volume><pub-id pub-id-type="pmid">38955182</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauvezin</surname><given-names>C</given-names></name><name><surname>Neufeld</surname><given-names>TP</given-names></name></person-group><article-title>Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion</article-title><source>Autophagy</source><year>2015</year><volume>11</volume><fpage>1437</fpage><lpage>1438</lpage><pub-id pub-id-type="pmcid">PMC4590655</pub-id><pub-id pub-id-type="pmid">26156798</pub-id><pub-id pub-id-type="doi">10.1080/15548627.2015.1066957</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarjányi</surname><given-names>O</given-names></name><etal/></person-group><article-title>Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><elocation-id>5808</elocation-id><pub-id pub-id-type="pmcid">PMC8987075</pub-id><pub-id pub-id-type="pmid">35388084</pub-id><pub-id pub-id-type="doi">10.1038/s41598-022-09763-z</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation</article-title><source>Cardiovasc Res</source><year>2006</year><volume>72</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">16950237</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appelqvist</surname><given-names>H</given-names></name><etal/></person-group><article-title>Attenuation of the Lysosomal Death Pathway by Lysosomal Cholesterol Accumulation</article-title><source>Am J Pathol</source><year>2011</year><volume>178</volume><fpage>629</fpage><lpage>639</lpage><pub-id pub-id-type="pmcid">PMC3069902</pub-id><pub-id pub-id-type="pmid">21281795</pub-id><pub-id pub-id-type="doi">10.1016/j.ajpath.2010.10.030</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M</given-names></name><etal/></person-group><article-title>The structure and global distribution of the endoplasmic reticulum network are actively regulated by lysosomes</article-title><source>Sci Adv</source><year>2020</year><volume>6</volume><elocation-id>eabc7209</elocation-id><pub-id pub-id-type="pmcid">PMC7744115</pub-id><pub-id pub-id-type="pmid">33328230</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abc7209</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagas</surname><given-names>NE</given-names></name><name><surname>Venkatachalam</surname><given-names>K</given-names></name></person-group><article-title>Roles for the Endoplasmic Reticulum in Regulation of Neuronal Calcium Homeostasis</article-title><source>Cells</source><year>2019</year><volume>8</volume><fpage>1232</fpage><pub-id pub-id-type="pmcid">PMC6829861</pub-id><pub-id pub-id-type="pmid">31658749</pub-id><pub-id pub-id-type="doi">10.3390/cells8101232</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perni</surname><given-names>M</given-names></name><etal/></person-group><article-title>A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity</article-title><source>Proc Natl Acad Sci</source><year>2017</year><volume>114</volume><fpage>E1009</fpage><lpage>E1017</lpage><pub-id pub-id-type="pmcid">PMC5307473</pub-id><pub-id pub-id-type="pmid">28096355</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1610586114</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iuliano</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cholesterol metabolites exported from human brain</article-title><source>Steroids</source><year>2015</year><volume>99</volume><fpage>189</fpage><lpage>193</lpage><pub-id pub-id-type="pmcid">PMC4503873</pub-id><pub-id pub-id-type="pmid">25668615</pub-id><pub-id pub-id-type="doi">10.1016/j.steroids.2015.01.026</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>JR</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name></person-group><article-title>Synapses in neurodegenerative diseases</article-title><source>BMB Rep</source><year>2017</year><volume>50</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmcid">PMC5458673</pub-id><pub-id pub-id-type="pmid">28270301</pub-id><pub-id pub-id-type="doi">10.5483/BMBRep.2017.50.5.038</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pchitskaya</surname><given-names>E</given-names></name><name><surname>Popugaeva</surname><given-names>E</given-names></name><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><article-title>Calcium signaling and molecular mechanisms underlying neurodegenerative diseases</article-title><source>Cell Calcium</source><year>2018</year><volume>70</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmcid">PMC5748019</pub-id><pub-id pub-id-type="pmid">28728834</pub-id><pub-id pub-id-type="doi">10.1016/j.ceca.2017.06.008</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease</article-title><source>Mol Neurodegener</source><year>2017</year><volume>12</volume><fpage>86</fpage><pub-id pub-id-type="pmcid">PMC5686812</pub-id><pub-id pub-id-type="pmid">29137651</pub-id><pub-id pub-id-type="doi">10.1186/s13024-017-0228-2</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarrouk</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid (DHA; C22:6 n-3)</article-title><source>Steroids</source><year>2015</year><volume>99</volume><fpage>238</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">25656786</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kölsch</surname><given-names>H</given-names></name><name><surname>Lütjohann</surname><given-names>D</given-names></name><name><surname>Tulke</surname><given-names>A</given-names></name><name><surname>Björkhem</surname><given-names>I</given-names></name><name><surname>Rao</surname><given-names>ML</given-names></name></person-group><article-title>The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells</article-title><source>Brain Res</source><year>1999</year><volume>818</volume><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">9914453</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marambaud</surname><given-names>P</given-names></name><name><surname>Dreses-Werringloer</surname><given-names>U</given-names></name><name><surname>Vingtdeux</surname><given-names>V</given-names></name></person-group><article-title>Calcium signaling in neurodegeneration</article-title><source>Mol Neurodegener</source><year>2009</year><volume>4</volume><fpage>20</fpage><pub-id pub-id-type="pmcid">PMC2689218</pub-id><pub-id pub-id-type="pmid">19419557</pub-id><pub-id pub-id-type="doi">10.1186/1750-1326-4-20</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Plasma membrane ion permeability induced by mutant α-synuclein contributes to the degeneration of neural cells</article-title><source>J Neurochem</source><year>2006</year><volume>97</volume><elocation-id>10711077</elocation-id><pub-id pub-id-type="pmid">16606366</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demuro</surname><given-names>A</given-names></name><etal/></person-group><article-title>Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers *?</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>17294</fpage><lpage>17300</lpage><pub-id pub-id-type="pmid">15722360</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Endoplasmic reticulum and lysosomal Ca2+ stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts</article-title><source>Cell Calcium</source><year>2016</year><volume>59</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type="pmcid">PMC4751977</pub-id><pub-id pub-id-type="pmid">26691915</pub-id><pub-id pub-id-type="doi">10.1016/j.ceca.2015.11.002</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer’s Disease-Linked Mutations</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>981</fpage><lpage>993</lpage><pub-id pub-id-type="pmcid">PMC3241869</pub-id><pub-id pub-id-type="pmid">16959576</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.059</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Marchi</surname><given-names>S</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name></person-group><article-title>The machineries, regulation and cellular functions of mitochondrial calcium</article-title><source>Nat Rev Mol Cell Biol</source><year>2018</year><volume>19</volume><fpage>713</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">30143745</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>PP</given-names></name><name><surname>Hirsch</surname><given-names>EC</given-names></name><name><surname>Hunot</surname><given-names>S</given-names></name></person-group><article-title>Understanding Dopaminergic Cell Death Pathways in Parkinson Disease</article-title><source>Neuron</source><year>2016</year><volume>90</volume><fpage>675</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">27196972</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjöström</surname><given-names>PJ</given-names></name><name><surname>Nelson</surname><given-names>SB</given-names></name></person-group><article-title>Spike timing, calcium signals and synaptic plasticity</article-title><source>Curr Opin Neurobiol</source><year>2002</year><volume>12</volume><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">12049938</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><article-title>Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson’s Disease*</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>10736</fpage><lpage>10741</lpage><pub-id pub-id-type="pmcid">PMC3624453</pub-id><pub-id pub-id-type="pmid">23086948</pub-id><pub-id pub-id-type="doi">10.1074/jbc.R112.410530</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenton</surname><given-names>AR</given-names></name><name><surname>Jongens</surname><given-names>TA</given-names></name><name><surname>Holzbaur</surname><given-names>ELF</given-names></name></person-group><article-title>Mitochondrial dynamics: shaping and remodeling an organelle network</article-title><source>Curr Opin Cell Biol</source><year>2021</year><volume>68</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="pmcid">PMC7925334</pub-id><pub-id pub-id-type="pmid">32961383</pub-id><pub-id pub-id-type="doi">10.1016/j.ceb.2020.08.014</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knott</surname><given-names>AB</given-names></name><name><surname>Perkins</surname><given-names>G</given-names></name><name><surname>Schwarzenbacher</surname><given-names>R</given-names></name><name><surname>Bossy-Wetzel</surname><given-names>E</given-names></name></person-group><article-title>Mitochondrial fragmentation in neurodegeneration</article-title><source>Nat Rev Neurosci</source><year>2008</year><volume>9</volume><fpage>505</fpage><lpage>518</lpage><pub-id pub-id-type="pmcid">PMC2711514</pub-id><pub-id pub-id-type="pmid">18568013</pub-id><pub-id pub-id-type="doi">10.1038/nrn2417</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Okamoto</surname><given-names>K-I</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><article-title>The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses</article-title><source>Cell</source><year>2004</year><volume>119</volume><fpage>873</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">15607982</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stowers</surname><given-names>RS</given-names></name><name><surname>Megeath</surname><given-names>LJ</given-names></name><name><surname>Górska-Andrzejak</surname><given-names>J</given-names></name><name><surname>Meinertzhagen</surname><given-names>IA</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><article-title>Axonal Transport of Mitochondria to Synapses Depends on Milton, a Novel <italic>Drosophila</italic> Protein</article-title><source>Neuron</source><year>2002</year><volume>36</volume><fpage>1063</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">12495622</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J-S</given-names></name><name><surname>Davis</surname><given-names>RL</given-names></name><name><surname>Sue</surname><given-names>CM</given-names></name></person-group><article-title>Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives</article-title><source>Curr Neurol Neurosci Rep</source><year>2018</year><volume>18</volume><fpage>21</fpage><pub-id pub-id-type="pmcid">PMC5882770</pub-id><pub-id pub-id-type="pmid">29616350</pub-id><pub-id pub-id-type="doi">10.1007/s11910-018-0829-3</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><article-title>Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances</article-title><source>Mol Neurodegener</source><year>2020</year><volume>15</volume><fpage>30</fpage><pub-id pub-id-type="pmcid">PMC7257174</pub-id><pub-id pub-id-type="pmid">32471464</pub-id><pub-id pub-id-type="doi">10.1186/s13024-020-00376-6</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nury</surname><given-names>T</given-names></name><etal/></person-group><article-title>Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3)</article-title><source>Steroids</source><year>2015</year><volume>99</volume><fpage>194</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">25683890</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>The cytotoxicity of 27-hydroxycholesterol in co-cultured SH-SY5Y cells and C6 cells</article-title><source>Neurosci Lett</source><year>2016</year><volume>632</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">27592060</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das Gupta</surname><given-names>A</given-names></name><etal/></person-group><article-title>27-Hydroxycholesterol Enhances Secretion of Extracellular Vesicles by ROS-Induced Dysregulation of Lysosomes</article-title><source>Endocrinology</source><year>2024</year><volume>165</volume><elocation-id>bqae127</elocation-id><pub-id pub-id-type="pmcid">PMC11448339</pub-id><pub-id pub-id-type="pmid">39298675</pub-id><pub-id pub-id-type="doi">10.1210/endocr/bqae127</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cigliano</surname><given-names>L</given-names></name><etal/></person-group><article-title>24S-hydroxycholesterol affects redox homeostasis in human glial U-87MG cells</article-title><source>Mol Cell Endocrinol</source><year>2019</year><volume>486</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">30802527</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezine</surname><given-names>M</given-names></name><etal/></person-group><article-title>Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0)</article-title><source>Biochimie</source><year>2018</year><volume>153</volume><fpage>56</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">29462682</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>P</given-names></name><etal/></person-group><article-title>27-hydroxycholesterol and the expression of three estrogen-sensitive proteins in MCF7 cells</article-title><source>Oncol Rep</source><year>2012</year><volume>28</volume><fpage>992</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">22710948</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Divakaruni</surname><given-names>AS</given-names></name><name><surname>Paradyse</surname><given-names>A</given-names></name><name><surname>Ferrick</surname><given-names>DA</given-names></name><name><surname>Murphy</surname><given-names>AN</given-names></name><name><surname>Jastroch</surname><given-names>M</given-names></name></person-group><chapter-title>Chapter Sixteen -Analysis and Interpretation of Microplate-Based Oxygen Consumption and pH Data</chapter-title><source>Methods in Enzymology</source><person-group person-group-type="editor"><name><surname>Murphy</surname><given-names>AN</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><publisher-name>Academic Press</publisher-name><year>2014</year><volume>547</volume><fpage>309</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">25416364</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Fovez</surname><given-names>Q</given-names></name><name><surname>Germain</surname><given-names>N</given-names></name><name><surname>Khamari</surname><given-names>R</given-names></name><name><surname>Kluza</surname><given-names>J</given-names></name></person-group><article-title>Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells</article-title><source>FASEB J</source><year>2020</year><volume>34</volume><fpage>13106</fpage><lpage>13124</lpage><pub-id pub-id-type="pmid">32808332</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group><article-title>27-Hydroxycholesterol Contributes to Lysosomal Membrane Permeabilization-Mediated Pyroptosis in Co-cultured SH-SY5Y Cells and C6 Cells</article-title><source>Front Mol Neurosci</source><year>2019</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC6405519</pub-id><pub-id pub-id-type="pmid">30881285</pub-id><pub-id pub-id-type="doi">10.3389/fnmol.2019.00014</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özkan</surname><given-names>N</given-names></name><etal/></person-group><article-title>ER -lysosome contacts at a pre-axonal region regulate axonal lysosome availability</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><elocation-id>4493</elocation-id><pub-id pub-id-type="pmcid">PMC8302662</pub-id><pub-id pub-id-type="pmid">34301956</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-24713-5</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>AC</given-names></name><name><surname>Loh</surname><given-names>SHY</given-names></name><name><surname>Martins</surname><given-names>LM</given-names></name></person-group><article-title>Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson’s disease</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><comment>e467-e467</comment><pub-id pub-id-type="pmcid">PMC3563993</pub-id><pub-id pub-id-type="pmid">23328674</pub-id><pub-id pub-id-type="doi">10.1038/cddis.2012.205</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration</article-title><source>Proc Natl Acad Sci</source><year>2015</year><volume>112</volume><fpage>11696</fpage><lpage>11701</lpage><pub-id pub-id-type="pmcid">PMC4577198</pub-id><pub-id pub-id-type="pmid">26324925</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1500624112</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Evans</surname><given-names>E</given-names></name><name><surname>Waller-Evans</surname><given-names>H</given-names></name></person-group><article-title>Lysosomal Ca2+ Homeostasis and Signaling in Health and Disease</article-title><source>Cold Spring Harb Perspect Biol</source><year>2020</year><volume>12</volume><elocation-id>a035311</elocation-id><pub-id pub-id-type="pmcid">PMC7263086</pub-id><pub-id pub-id-type="pmid">31653642</pub-id><pub-id pub-id-type="doi">10.1101/cshperspect.a035311</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>BS</given-names></name><name><surname>Eden</surname><given-names>ER</given-names></name><name><surname>Schapira</surname><given-names>AH</given-names></name><name><surname>Futter</surname><given-names>CE</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name></person-group><article-title>Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals</article-title><source>J Cell Sci</source><year>2013</year><volume>126</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="pmcid">PMC4208295</pub-id><pub-id pub-id-type="pmid">23108667</pub-id><pub-id pub-id-type="doi">10.1242/jcs.118836</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Davis</surname><given-names>LC</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><chapter-title>Chapter 9 -Imaging approaches to measuring lysosomal calcium</chapter-title><source>Methods in Cell Biology</source><person-group person-group-type="editor"><name><surname>Platt</surname><given-names>F</given-names></name><name><surname>Platt</surname><given-names>N</given-names></name></person-group><publisher-name>Academic Press</publisher-name><year>2015</year><volume>126</volume><fpage>159</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">25665446</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Evans</surname><given-names>E</given-names></name><etal/></person-group><article-title>Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium</article-title><source>Nat Med</source><year>2008</year><volume>14</volume><fpage>1247</fpage><lpage>1255</lpage><pub-id pub-id-type="pmid">18953351</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Juan-Sanz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Axonal endoplasmic reticulum Ca2+ content controls release probability in CNS nerve terminals</article-title><source>Neuron</source><year>2017</year><volume>93</volume><fpage>867</fpage><lpage>881</lpage><elocation-id>e6</elocation-id><pub-id pub-id-type="pmcid">PMC5325711</pub-id><pub-id pub-id-type="pmid">28162809</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2017.01.010</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanaday</surname><given-names>NL</given-names></name><name><surname>Kavalali</surname><given-names>ET</given-names></name></person-group><article-title>Role of the Endoplasmic Reticulum in Synaptic Transmission</article-title><source>Curr Opin Neurobiol</source><year>2022</year><volume>73</volume><elocation-id>102538</elocation-id><pub-id pub-id-type="pmcid">PMC9167765</pub-id><pub-id pub-id-type="pmid">35395547</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2022.102538</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Al-Nusaif</surname><given-names>M</given-names></name><name><surname>Le</surname><given-names>W</given-names></name></person-group><article-title>The role of the tubular endoplasmic reticulum in the axonal degeneration associated with neurodegenerative disorders</article-title><source>Ageing Neurodegener Dis</source><year>2023</year><volume>3</volume><elocation-id>N/A-N/A</elocation-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paillusson</surname><given-names>S</given-names></name><etal/></person-group><article-title>α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production</article-title><source>Acta Neuropathol. (Berl.)</source><year>2017</year><volume>134</volume><fpage>129</fpage><lpage>149</lpage><pub-id pub-id-type="pmcid">PMC5486644</pub-id><pub-id pub-id-type="pmid">28337542</pub-id><pub-id pub-id-type="doi">10.1007/s00401-017-1704-z</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottolini</surname><given-names>D</given-names></name><name><surname>Calì</surname><given-names>T</given-names></name><name><surname>Negro</surname><given-names>A</given-names></name><name><surname>Brini</surname><given-names>M</given-names></name></person-group><article-title>The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering</article-title><source>Hum Mol Genet</source><year>2013</year><volume>22</volume><fpage>2152</fpage><lpage>2168</lpage><pub-id pub-id-type="pmid">23418303</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urano</surname><given-names>Y</given-names></name><name><surname>Ho Vo</surname><given-names>D-K</given-names></name><name><surname>Hirofumi</surname><given-names>A</given-names></name><name><surname>Noguchi</surname><given-names>N</given-names></name></person-group><article-title>24(S)-Hydroxycholesterol induces ER dysfunction-mediated unconventional cell death</article-title><source>Cell Death Discov</source><year>2019</year><volume>5</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6611791</pub-id><pub-id pub-id-type="pmid">31285856</pub-id><pub-id pub-id-type="doi">10.1038/s41420-019-0192-4</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Romero</surname><given-names>A</given-names></name><name><surname>Montpeyó</surname><given-names>M</given-names></name><name><surname>Martinez-Vicente</surname><given-names>M</given-names></name></person-group><article-title>The Emerging Role of the Lysosome in Parkinson’s Disease</article-title><source>Cells</source><year>2020</year><volume>9</volume><fpage>2399</fpage><pub-id pub-id-type="pmcid">PMC7692401</pub-id><pub-id pub-id-type="pmid">33147750</pub-id><pub-id pub-id-type="doi">10.3390/cells9112399</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todkar</surname><given-names>K</given-names></name><name><surname>Ilamathi</surname><given-names>HS</given-names></name><name><surname>Germain</surname><given-names>M</given-names></name></person-group><article-title>Mitochondria and Lysosomes: Discovering Bonds</article-title><source>Front Cell Dev Biol</source><year>2017</year><volume>5</volume><fpage>106</fpage><pub-id pub-id-type="pmcid">PMC5725469</pub-id><pub-id pub-id-type="pmid">29270406</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2017.00106</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CA</given-names></name><name><surname>Blackstone</surname><given-names>C</given-names></name></person-group><article-title>ER morphology and endo-lysosomal crosstalk: functions and disease implications</article-title><source>Biochim. Biophys. Acta Mol Cell Biol Lipids</source><year>2020</year><volume>1865</volume><elocation-id>158544</elocation-id><pub-id pub-id-type="pmcid">PMC6904894</pub-id><pub-id pub-id-type="pmid">31678515</pub-id><pub-id pub-id-type="doi">10.1016/j.bbalip.2019.158544</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knupp</surname><given-names>J</given-names></name><name><surname>Pletan</surname><given-names>ML</given-names></name><name><surname>Arvan</surname><given-names>P</given-names></name><name><surname>Tsai</surname><given-names>B</given-names></name></person-group><article-title>Autophagy of the ER: the secretome finds the lysosome</article-title><source>FEBS J</source><year>2023</year><volume>290</volume><fpage>5656</fpage><lpage>5673</lpage><pub-id pub-id-type="pmcid">PMC11044768</pub-id><pub-id pub-id-type="pmid">37920925</pub-id><pub-id pub-id-type="doi">10.1111/febs.16986</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrisch</surname><given-names>RG</given-names></name><name><surname>Gumbin</surname><given-names>SC</given-names></name><name><surname>Wisniewski</surname><given-names>BT</given-names></name><name><surname>Lackner</surname><given-names>LL</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><article-title>Fission and fusion machineries converge at ER contact sites to regulate mitochondrial morphology</article-title><source>J Cell Biol</source><year>2020</year><volume>219</volume><elocation-id>e201911122</elocation-id><pub-id pub-id-type="pmcid">PMC7147108</pub-id><pub-id pub-id-type="pmid">32328629</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201911122</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanaday</surname><given-names>NL</given-names></name><name><surname>Kavalali</surname><given-names>ET</given-names></name></person-group><article-title>Role of the Endoplasmic Reticulum in Synaptic Transmission</article-title><source>Curr Opin Neurobiol</source><year>2022</year><volume>73</volume><elocation-id>102538</elocation-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>24S-HC and 27-HC impair calcium signalling in i<sup>3</sup> neurons.</title><p><bold>(a)</bold> A brief overview of the calcium imaging methodology and subsequent data analysis. i<sup>3</sup> neurons transduced with the Incucyte Neuroburst Orange lentivirus were imaged using widefield microscopy, scale bar = 200 μm. Individual somas were identified (yellow rectangles) after thresholding, scale bar = 100 μm. The fluorescence intensity fluctuation of each soma over time was extracted, then normalised to ΔF/F<sub>0</sub>. <bold>(b)</bold> Calcium imaging heatmaps showing activity of i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 1 day. <bold>(c) - (f)</bold> The relative change in resting calcium levels (F<sub>0</sub>), relative calcium spike amplitude (peak ΔF/F<sub>0</sub>), calcium spike rate and calcium spike synchronicity of i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC over 4 days. Data were normalised to Day 0 (pretreatment) and presented as floating bar plots (min to max), with a line indicating the mean. One field of view was imaged per well, and each data point represents a single well. <bold>(c), (d)</bold> and <bold>(f)</bold> were analysed with two-way ANOVA using Dunnett’s multiple comparisons tests, while <bold>(e)</bold> was analysed with mixed-effects analysis using Dunnett’s multiple comparisons tests. ns is not significant, * is p&lt;0.05 and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified.</p></caption><graphic xlink:href="EMS206431-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>24S-HC and 27-HC cause mitochondrial dysfunction.</title><p><bold>(a)</bold> Top row shows representative SIM images of mitochondria in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 3 days; scale bar = 10 μm. Bottom row shows the zoomed-in area indicated by the cyan rectangle; scale bar = 5 μm. <bold>(b)</bold> The circularity of mitochondria is presented as means ± SD. Each data point represents an individual image. Kruskal-Wallis test with Dunn’s multiple comparisons, where ns is not significant and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified. <bold>(c)</bold> Seahorse Mito Stress Tests show the oxygen consumption rate (OCR) level change of COS-7 cells treated with 10 μM cholesterol, 24S-HC or 27-HC daily for two days. Data were normalised to the value of the untreated sample in each repeat. <bold>(d)</bold> The spare respiratory capacity was presented as floating bar plots (min to max), with a line indicating the mean. Each data point represents an individual well. Brown-Forsythe ANOVA test with Dunnett’s T3 multiple comparisons tests, where ns is not significant and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified.</p></caption><graphic xlink:href="EMS206431-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>24S-HC and 27-HC cause lysosomal dysfunction in i<sup>3</sup> neurons.</title><p><bold>(a)</bold> Top row shows representative SIM images of lysosomes in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 3 days. 10 μM U18666A was added for 3 days as a positive control. Bottom row: Mitochondria were co-stained to identify the soma, and the nucleus was manually outlined in white to indicate its location. Scale bar = 5 μm. <bold>(b)</bold> The size of lysosomes is presented as means ± S.D. Each data point represents an individual image. Kruskal-Wallis test with Dunn’s multiple comparisons, where ns is not significant, * is p&lt;0.05 and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified. <bold>(c)</bold> Top row shows representative SIM images of lysosomes in i<sup>3</sup> neurons treated with 10 μM 27-HC, showing leakage of SiR-lysosome dye (orange arrows). Scale bar = 5 μm. Bottom row: the ER was labelled with an mEmerald-KDEL lentivirus to identify the soma. <bold>(d)</bold> The percentage of cells with dye leakage was plotted. Data from N = 3 independent experiments were quantified. <bold>(e)</bold> Representative widefield images of DQ-BSA fluorescence in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 3 days. The ER was labelled to identify the soma. 0.5 μM bafilomycin A1 was added for 6 h as a negative control. Scale bar = 20 μm. <bold>(f)</bold> The intensity of DQ-BSA in each soma is presented as means ± S.D. Each data point represents an individual image. Representative images in <bold>(e)</bold> are shown at higher magnification to enhance visibility and do not reflect the full field of view used for analysis. Kruskal-Wallis test with Dunn’s multiple comparisons, where ns is not significant and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified.</p></caption><graphic xlink:href="EMS206431-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>24S-HC and 27-HC cause ER disturbances in i<sup>3</sup> neurons.</title><p><bold>(a)</bold> Representative SIM images of the ER, mitochondria and lysosomes in the axons of i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 3 days. Scale bar = 4 μm. Axonal swellings were observed in 24S-HC and 27-HC treated conditions (orange arrows). <bold>(b)</bold> The percentage of axons with swelling was plotted. Data from N = 4 independent experiments were quantified. <bold>(c)</bold> Representative widefield images of ER-GCaMP6 fluorescence in i<sup>3</sup> neurons treated with 10 μM cholesterol, 24S-HC or 27-HC for 3 days. Scale bar = 50 μm. <bold>(d)</bold> The normalised intensity of ER-GCaMP6 is presented as means ± S.D. Each data point represents an individual image. Representative images in <bold>(c)</bold> are shown at higher magnification to enhance visibility and do not reflect the full field of view used for analysis. Kruskal-Wallis test with Dunn’s multiple comparisons, where ns is not significant and **** is p&lt;0.0001. Data from N = 3 independent experiments were quantified.</p></caption><graphic xlink:href="EMS206431-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title><sup>1</sup>H-<sup>15</sup>N HSQC NMR spectra detected chemical shift perturbations (CSP) of the resonances of monomeric aSyn (10 μM) in the presence of three molar equivalents of cholesterol, 24S-HC or 27-HC (30 μM).</title><p><bold>(a)</bold> A few of CSP in the <sup>1</sup>H-15N resonances of aSyn amide backbone were found in the presence of cholesterol. These are primarily located in the membrane binding region at the N-terminal 90 residues (residues 9, 21, 42, 54, 58, 71, 75). Stronger effects were found in the case of 24S-HC <bold>(b)</bold> and 27-HC <bold>(c)</bold>, with CSP extending to additional residues (e.g., 22, 31, 38, 40, 43, 64, 81, 84, 87).</p></caption><graphic xlink:href="EMS206431-f005"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Key reagents</title></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="top">Reagent or Resource</th><th align="center" valign="top">Source</th><th align="center" valign="top">Identifier</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="3"><bold>i<sup>3</sup> neuronal cell culture</bold></td></tr><tr><td align="center" valign="top">Stem Flex Medium</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">A3349401</td></tr><tr><td align="center" valign="top">Greiner CELLSTAR 6 well cell culture plates</td><td align="center" valign="top">Greiner Bio-One</td><td align="center" valign="top">657160</td></tr><tr><td align="center" valign="top">Vitronectin (VTN-N) Recombinant Human Protein, Truncated</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">A14700</td></tr><tr><td align="center" valign="top">StemPro™ Accutase™ Cell Dissociation Reagent</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">A1110501</td></tr><tr><td align="center" valign="top">Dulbecco’s Modified Eagle Medium:Nutrient Mixture F-12 (DMEM / F-12), HEPES</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">11330032</td></tr><tr><td align="center" valign="top">N-2 Supplement (100X), 5mL</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">17502-048</td></tr><tr><td align="center" valign="top">Non-Essential Amino Acids Solution (100X)</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">11140050</td></tr><tr><td align="center" valign="top">Antibiotic-Antimycotic (100X)</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">15240062</td></tr><tr><td align="center" valign="top">2-Mercaptoethanol (50 mM)</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">31350010</td></tr><tr><td align="center" valign="top">Doxycycline hyclate</td><td align="center" valign="top">Sigma</td><td align="center" valign="top">D9891-1G</td></tr><tr><td align="center" valign="top">Geltrex™ LDEV-Free, hESC-Qualified, Reduced Growth Factor Basement Membrane Matrix</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">A1413302</td></tr><tr><td align="center" valign="top">Neurobasal medium 1X minus phenol red</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">12348017</td></tr><tr><td align="center" valign="top">B-27™ Supplement (50X), serum free</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">17504044</td></tr><tr><td align="center" valign="top">GlutaMAX™ Supplement</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">35050038</td></tr><tr><td align="center" valign="top">Recombinant Human NT-3 (10ug)</td><td align="center" valign="top">Peprotech</td><td align="center" valign="top">450-03-10UG</td></tr><tr><td align="center" valign="top">Human BDNF Recombinant Protein, 10 ug</td><td align="center" valign="top">PeproTech</td><td align="center" valign="top">450-02</td></tr><tr><td align="center" valign="top">ROCK Inhibitor (Y-27632)</td><td align="center" valign="top">BD Biosciences</td><td align="center" valign="top">562822</td></tr><tr><td align="center" valign="top">Nunc LabTek II Chambered Coverglass, 8 chambers (pack of 16)</td><td align="center" valign="top">Thermo Scientific</td><td align="center" valign="top">155409PK</td></tr><tr><td align="center" valign="top">Corning® 96-well Flat Clear Bottom Black Polystyrene TC-treated Microplates, Individually Wrapped, with Lid, Sterile</td><td align="center" valign="top">Corning</td><td align="center" valign="top">3603</td></tr><tr><td align="center" valign="top">Poly-L-lysine solution, 0.01%</td><td align="center" valign="top">Sigma</td><td align="center" valign="top">P4707</td></tr><tr><td align="center" valign="top">Incucyte® Neuroburst Orange Lentivirus (Synapsin)</td><td align="center" valign="top">Sartorius</td><td align="center" valign="top">4736</td></tr><tr><td align="left" valign="top" colspan="3"><bold>COS-7 and HEK cell culture</bold></td></tr><tr><td align="center" valign="top">Dulbecco’s Modified Eagle’s Medium (DMEM) - high glucose</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">D6546-500ML</td></tr><tr><td align="center" valign="top">Fetal Bovine Serum (FBS)</td><td align="center" valign="top">Gibco</td><td align="center" valign="top">A5256801</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Plasmids and transfection reagents</bold></td></tr><tr><td align="center" valign="top">pLV_CMV_mEmerald-KDEL</td><td align="center" valign="top">Made by Dr Edward Avezov’s group</td><td align="center" valign="top">-</td></tr><tr><td align="center" valign="top">ER-GCaMP-150</td><td align="center" valign="top">Addgene</td><td align="center" valign="top">Plasmid #86918</td></tr><tr><td align="center" valign="top">pMDLg_pRRE</td><td align="center" valign="top">Addgene</td><td align="center" valign="top">Plasmid #12251</td></tr><tr><td align="center" valign="top">pRSV-Rev</td><td align="center" valign="top">Addgene</td><td align="center" valign="top">Plasmid #12253</td></tr><tr><td align="center" valign="top">pMD2.G</td><td align="center" valign="top">Addgene</td><td align="center" valign="top">Plasmid #12259</td></tr><tr><td align="center" valign="top">Lipofectamine 2000 Transfection Reagent</td><td align="center" valign="top">Invitrogen</td><td align="center" valign="top">11668027</td></tr><tr><td align="center" valign="top">Polyethyleneimine (PEI), linear, M.W. 25,000</td><td align="center" valign="top">Thermo Scientific Chemicals</td><td align="center" valign="top">043896.01</td></tr><tr><td align="center" valign="top">PEG 8000 Powder, Molecular Biology Grade</td><td align="center" valign="top">Promega</td><td align="center" valign="top">V3011</td></tr><tr><td align="center" valign="top">NaCl</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">S9888</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Cholesterols and Drugs</bold></td></tr><tr><td align="center" valign="top">Cholesterol (ovine)</td><td align="center" valign="top">Avanti Polar Lipid</td><td align="center" valign="top">700000P</td></tr><tr><td align="center" valign="top">24(S)-Hydroxycholesterol</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">SML1648</td></tr><tr><td align="center" valign="top">27-hydroxycholesterol</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">SML2042</td></tr><tr><td align="center" valign="top">Dimethyl sulfoxide (DMSO)</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">D8418-100ML</td></tr><tr><td align="center" valign="top">U18666A</td><td align="center" valign="top">Sigma-Aldrich</td><td align="center" valign="top">662015</td></tr><tr><td align="center" valign="top">Bafilomycin A1, (V)-ATPase inhibitor-10 ug</td><td align="center" valign="top">Abcam</td><td align="center" valign="top">ab120497</td></tr><tr><td align="center" valign="top">MG-132</td><td align="center" valign="top">calbiochem</td><td align="center" valign="top">474791</td></tr><tr><td align="center" valign="top">Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)</td><td align="center" valign="top">Abcam</td><td align="center" valign="top">ab120081</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Dyes</bold></td></tr><tr><td align="center" valign="top">MitoTracker Deep Red</td><td align="center" valign="top">Invitrogen</td><td align="center" valign="top">M22426</td></tr><tr><td align="center" valign="top">MitoTracker Orange</td><td align="center" valign="top">Invitrogen</td><td align="center" valign="top">M7510</td></tr><tr><td align="center" valign="top">SiR-lysosome kit</td><td align="center" valign="top">Spirochrome</td><td align="center" valign="top">SC012</td></tr><tr><td align="center" valign="top">DQ-Red BSA</td><td align="center" valign="top">Invitrogen</td><td align="center" valign="top">D12051</td></tr><tr><td align="left" valign="top" colspan="3"><bold>Seahorse assay</bold></td></tr><tr><td align="center" valign="top">Seahorse XF Cell Mito Stress Test Kit</td><td align="center" valign="top">Agilent</td><td align="center" valign="top">103015-100</td></tr><tr><td align="center" valign="top">Seahorse FluxPaks</td><td align="center" valign="top">Agilent</td><td align="center" valign="top">103793-100</td></tr></tbody></table></table-wrap></floats-group></article>